This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant Agreement No. 956851.

Science Communication

COLOTAN Symposia

The COLOTAN 1st Symposium “Colon targeting of drugs: current state of the art” – click to find symposium presentations and recording.

The COLOTAN 2nd Symposium “Drug disposition in the colon” – click to find symposium presentations and recording.

The COLOTAN 3rd Symposium “Gut disorders and possible impact on colonic drug targeting” – click to find symposium presentations and recording.


COLOTAN Journal Articles

  1. L. E. McCoubrey, A. Favaron, A. Awad, M. Orlu, S. Gaisford, A. W. Basit, Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics, Journal of Controlled Release 2023, DOI: 10.1016/j.jconrel.2022.12.029
  2. A. L. Nichols, Z. Blumenfeld, L. Luebbert, H. J. Knox, A. K. Muthusamy, J. S. Marvin, C. H. Kim, S. N. Grant, D. P. Walton, B. N. Cohen, R. Hammar, L. L. Looger, P. Artursson, D. A. Dougherty, H. A. Lester, Selective Serotonin Reuptake Inhibitors Within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane, Journal of Neuroscience, 2023, DOI:
  3. R. Hammar, M. E. Sellin, P. Artursson, Epithelial and microbial determinants of colonic drug distribution, European Journal of Pharmaceutical Sciences, 2023, DOI: 10.1016/j.ejps.2023.106389
  4. C. Tannergren, H. Jadhav, E. Eckernäs, J. Fagerberg, P. Augustijns, E. Sjögren, Physiologically based biopharmaceutics modeling of regional and colon absorption in humans, European Journal of Pharmaceutics and Biopharmaceutics, DOI: 10.1016/j.ejpb.2023.03.013
  5. L. Gnatzy, G. Ismailos, M. Vertzoni, C. Reppas, Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: challenges and opportunities, European Journal of Pharmaceutical Sciences, DOI: 10.1016/j.ejps.2023.106510
  6. H. Jadhav, P. Augustijns, C. Tannergren, Approaches to Account for Colon Absorption in Physiologically Based Biopharmaceutics Modeling of Extended-Release Drug Products, Molecular Pharmaceutics, 2023, DOI: 10.1021/acs.molpharmaceut.3c00683, download paper.